Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Observational Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity

NCT03418961 is registered in ClinicalTrials.gov with SWOG Cancer Research Network as lead sponsor.

NCT NCT03418961
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03418961 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Observational Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity
Lead sponsor
SWOG Cancer Research Network
Phase
Phase 3
Overall status
Recruiting
Start date
November 1, 2017
Completion date
September 15, 2027
Enrollment
491 (estimated)
Sites
590

Conditions

As the registry lists them; a condition with its own page is linked.

cardiotoxicity, her2/neu positive, metastatic malignant neoplasm in the brain, recurrent breast carcinoma, stage iv breast cancer ajcc v6 and v7